- Home
- BRKRP vs KOYNU Comparison
BRKRP vs KOYNU Comparison
Compare BRKRP & KOYNU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKRP
- KOYNU
- Stock Information
- Founded
- BRKRP N/A
- KOYNU N/A
- Country
- BRKRP United States
- KOYNU United States
- Employees
- BRKRP 11396
- KOYNU N/A
- Industry
- BRKRP Biotechnology: Laboratory Analytical Instruments
- KOYNU
- Sector
- BRKRP Industrials
- KOYNU
- Exchange
- BRKRP Nasdaq
- KOYNU Nasdaq
- Market Cap
- BRKRP N/A
- KOYNU N/A
- IPO Year
- BRKRP N/A
- KOYNU 2025
- Fundamental
- Price
- BRKRP $289.84
- KOYNU $10.20
- Analyst Decision
- BRKRP
- KOYNU
- Analyst Count
- BRKRP 0
- KOYNU 0
- Target Price
- BRKRP N/A
- KOYNU N/A
- AVG Volume (30 Days)
- BRKRP N/A
- KOYNU N/A
- Earning Date
- BRKRP N/A
- KOYNU N/A
- Dividend Yield
- BRKRP N/A
- KOYNU N/A
- EPS Growth
- BRKRP N/A
- KOYNU N/A
- EPS
- BRKRP N/A
- KOYNU N/A
- Revenue
- BRKRP N/A
- KOYNU N/A
- Revenue This Year
- BRKRP N/A
- KOYNU N/A
- Revenue Next Year
- BRKRP N/A
- KOYNU N/A
- P/E Ratio
- BRKRP N/A
- KOYNU N/A
- Revenue Growth
- BRKRP N/A
- KOYNU N/A
- 52 Week Low
- BRKRP N/A
- KOYNU N/A
- 52 Week High
- BRKRP N/A
- KOYNU N/A
- Technical
- Relative Strength Index (RSI)
- BRKRP N/A
- KOYNU N/A
- Support Level
- BRKRP N/A
- KOYNU N/A
- Resistance Level
- BRKRP N/A
- KOYNU N/A
- Average True Range (ATR)
- BRKRP 0.00
- KOYNU 0.00
- MACD
- BRKRP 0.00
- KOYNU 0.00
- Stochastic Oscillator
- BRKRP 0.00
- KOYNU 0.00
About BRKRP Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.